Skip to content

Prospective Pilot Study of Robot-assisted Nipple Sparing Mastectomy (RNSM)

Prospective Pilot Study of Robot-Assisted Nipple Sparing Mastectomy (RNSM)

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04537312
Enrollment
4
Registered
2020-09-03
Start date
2020-11-17
Completion date
2026-10-31
Last updated
2025-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Ductal Breast Carcinoma In Situ, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prophylactic Mastectomy

Brief summary

This is a pilot study to determine safety, efficacy, and potential risks of robot assisted nipple sparing mastectomy (RNSM), by utilizing the daVinci surgical system.

Detailed description

With the advances of breast reconstruction after mastectomy for the treatment of breast diseases including breast cancer, surgical techniques have evolved to preserve the skin flaps and nipple areolar complex (NAC) to give better aesthetic outcome without compromising outcome. Mastectomy that preserves the NAC is called nipple sparing mastectomy (NSM). NSM can provide major psychosocial benefits for patients but is technically demanding and challenging to perform. Total mammary glandular excision in NSM can be technically challenging due to small size of the incision and poor visualization of dissection plane. Recent studies demonstrate feasibility and safety of performing minimally invasive robot-assisted NSM (RNSM). The technique of RNSM is still novel. This is a single-arm pilot study for feasibility and safety of RNSM.

Interventions

PROCEDURERobot-assisted Nipple Sparing Mastectomy

Under RNSM

OTHERSurvey Administration

ancillary correlative

DEVICERNSM

Robot-assisted Nipple Sparing Mastectomy

Sponsors

Ohio State University Comprehensive Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Surgical candidates, per standard of care for: * Nipple sparing resection and reconstruction OR * Prophylactic mastectomy for risk reduction mastectomy OR * Treatment of ductal carcinoma in-situ or clinically node negative cT1-T3 breast cancer * Surgical candidates for open NSM, per standard of care, with regards to patient anatomic factors and tumor location * Patient has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1

Exclusion criteria

* Pregnant or nursing women * Patients with: * Inflammatory breast cancer * Skin involvement with tumor * Pre-operative diagnosis (radiological or pathologic) of nipple-areola complex involvement with tumor * Grade 3 ptosis of nipple * Smokers with heavy current use of nicotine (defined as \> 20 cigarettes/day) * Patients that are high risk for anesthesia, as documented in medical record * Patients that do not have the ability to give informed consent * Prisoner status at surgical clinic visit * Bra cup size greater than C cup * Previous thoracic radiation history (for any reason)

Design outcomes

Primary

MeasureTime frameDescription
Perioperative Outcomes investigating the length of hospitalizationUp to 1 yearInvestigate the length of hospitalization for each patient
Complication rate of patients with Mastectomy flap (SKIN flap score)Up to 1 yearNumber of patients with mastectomy flap or nipple-areolar complex necrosis as measured using the SKIN flap score after surgery. Score of A1 indicates normal skin, D4 indicates total full thickness necrosis.
Perioperative Outcomes investigating the total duration of surgical timeUp to 1 yearInvestigate the total duration of the operation (surgical time data),
Perioperative Outcomes investigating length of surgery timeUp to 1 yearInvestigate the total duration of the operation (surgical time data) of each patient
Feasibility of removal of breast gland en bloc through RNSMUp to 1 yearMeasure number of patients who had breast removed en bloc through RNSM incision.
Complication rate of patients with bleeding requiring re-operationUp to 1 yearNumber of patients with bleeding requiring re-operation after RNSM.
Complication rate of patients with infection requiring antibiotics or re-operationUp to 1 yearNumber of patients with infection after surgery requiring antibiotics or re-operation.

Secondary

MeasureTime frameDescription
Surgeon musculoskeletal fatigue with RNSM using NMSQ questionnaireUp to 1 yearMusculo-Skeletal Questionnaire (NMSQ) from each surgeon performing surgery.
Patient Reported OutcomesUp to 1 yearMonofilament testing to test for sensation recovery after surgery from each participant. Semmes Weinstein monofilament exam; sensation to series of monofilament with different thickness, compare sensation to preoperative exam.
Surgeon musculoskeletal fatigue with RNSM using (SURG-TLX) surveyUp to 1 yearSurgery Task Load Index (SURG-TLX) survey from each surgeon performing surgery.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026